Friday, March 23, 2018
Company News: Page (1) of 1 - 03/06/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Novartis' Cosentyx® shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause
- 94% of patients regained their PASI 75 response and the majority re-achieved their PASI 90 or 100 response after 16 weeks of Cosentyx 300 mg retreatment(1)- Patients may need to pause treatment due ...
(March 06, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:USA,Medicine,Disease,healthcare,Surgery,Medication,Vitamins/Nutrition,Womens Health,Physician,Nurse,Health Technologist,Science,Internet Technology,Medical,Other,Medical Professionals,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • New Alzheimer's Association Report Reveals Sharp Increases in Alzheimer's Prevalence, Deaths and Cost of Care
  • Global Liquid Biopsy Market 2018-2025 by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type
  • Global Liquid Biopsy Market, Initiatives, Funding and 20 Company Profile Report 2018
  • Prominent Salk Institute Neuroscientist Joins Nemus Bioscience as Scientific Consultant
  • Diagnostic Imaging Market to be Driven by Increasing Incidence of Chronic Diseases, Development of New Healthcare Facilities and Growing Medical Tourism: Radiant Insights, Inc.

  • Lupus Advocacy Requests Granted in 2018 Budget Bill
  • Breakthrough in Photonic Biosensors Could Lead to Fast, Super-Accurate Diagnostics and Detection
  • Endoscopy Equipment Market to Gain from Increasing Consumer Preference Towards Less Intrusive Surgical Procedures: Radiant Insights, Inc.
  • The T.J. Martell Foundation Announces 17th Annual New York Family Day
  • GIMDx, Inc. and IncellDx, Inc. Announce Acceleration of Chinese Commercialization of HPV OncoTect Kit

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines